Grantham Mayo Van Otterloo & Co. LLC Acquires 137,841 Shares of Procter & Gamble Company (The) $PG

Grantham Mayo Van Otterloo & Co. LLC raised its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 33.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 548,025 shares of the company’s stock after purchasing an additional 137,841 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Procter & Gamble were worth $84,204,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Brighton Jones LLC boosted its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. boosted its position in Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after buying an additional 277 shares in the last quarter. Sivia Capital Partners LLC increased its holdings in shares of Procter & Gamble by 19.8% during the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after buying an additional 1,016 shares in the last quarter. Auxano Advisors LLC raised its stake in shares of Procter & Gamble by 10.8% in the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after acquiring an additional 714 shares during the last quarter. Finally, Schnieders Capital Management LLC. raised its stake in shares of Procter & Gamble by 2.8% in the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after acquiring an additional 809 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 12,827 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the transaction, the insider directly owned 12,639 shares in the company, valued at $2,026,158.09. This represents a 50.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. The trade was a 50.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 348,618 shares of company stock valued at $55,462,643 over the last three months. 0.20% of the stock is owned by insiders.

Procter & Gamble Trading Down 0.1%

Shares of PG opened at $153.80 on Friday. The stock’s fifty day simple moving average is $152.35 and its 200-day simple moving average is $151.16. The firm has a market capitalization of $357.43 billion, a PE ratio of 22.79, a price-to-earnings-growth ratio of 5.13 and a beta of 0.37. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. The firm had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company’s revenue was up 1.5% on a year-over-year basis. During the same period last year, the company earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s payout ratio is 62.52%.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Wells Fargo & Company reiterated an “overweight” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Tuesday, February 17th. UBS Group increased their target price on Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a report on Friday, January 23rd. BNP Paribas Exane cut their price target on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a report on Friday, January 16th. TD Cowen downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and upped their price target for the stock from $150.00 to $156.00 in a research report on Tuesday, January 27th. Finally, JPMorgan Chase & Co. raised shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $157.00 to $165.00 in a report on Friday, January 23rd. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $168.33.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple dividend-themed pieces reaffirm PG’s status as a Dividend King/Aristocrat, underscoring steady dividend growth and defensive appeal for income-focused investors; that support can reduce downside for long-term holders. Dividend Aristocrats in a Shaky Market
• Neutral Sentiment: Market context is jittery (rising VIX, weak consumer sentiment and still-elevated Treasury yields); that macro uncertainty is affecting broad equity flows and may amplify short-term moves in consumer staples despite PG’s defensive profile. Dividend Aristocrats in a Shaky Market
• Negative Sentiment: A recent compendium of analyst notes flags margin pressure for Procter & Gamble, creating concern about near-term profitability and earnings leverage. That negative analyst tone can weigh on the stock. Top Research Reports for Procter & Gamble, American Express & TJX
• Negative Sentiment: Reports show PG shares have recently fallen more steeply than the broader market, indicating stronger selling pressure in short-term trading sessions. That price action can feed momentum-driven outflows. Procter & Gamble (PG) Falls More Steeply Than Broader Market
• Negative Sentiment: Insider selling was reported recently, which investors often view as a near-term negative signal and can amplify caution among holders and prospective buyers. Procter & Gamble (NYSE:PG) Shares Down 2.3% Following Insider Selling

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.